Lippincott, Williams & Wilkins, Journal of Hypertension, 6(28), p. 1313-1320, 2010
DOI: 10.1097/hjh.0b013e328337a9fd
Full text: Download
Metabolic syndrome is characterized by a marked sympathetic overactivity. It is unknown, however, whether the neuroadrenergic activation can be ascribed to obstructive sleep apnoea (OSA), OSA exerts potentiating effects on the metabolic syndrome-related sympathetic activation and reflex/metabolic variables (insulin resistance) participate at the phenomenon.